- Home
- PLUR vs PASG Comparison
PLUR vs PASG Comparison
Compare PLUR & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- PASG
- Stock Information
- Founded
- PLUR 2001
- PASG 2017
- Country
- PLUR Israel
- PASG United States
- Employees
- PLUR N/A
- PASG N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- PASG Health Care
- Exchange
- PLUR Nasdaq
- PASG Nasdaq
- Market Cap
- PLUR 26.7M
- PASG 31.1M
- IPO Year
- PLUR N/A
- PASG 2020
- Fundamental
- Price
- PLUR $6.75
- PASG $0.34
- Analyst Decision
- PLUR
- PASG Strong Buy
- Analyst Count
- PLUR 0
- PASG 3
- Target Price
- PLUR N/A
- PASG $7.67
- AVG Volume (30 Days)
- PLUR 24.8K
- PASG 192.0K
- Earning Date
- PLUR 05-09-2025
- PASG 05-13-2025
- Dividend Yield
- PLUR N/A
- PASG N/A
- EPS Growth
- PLUR N/A
- PASG N/A
- EPS
- PLUR N/A
- PASG N/A
- Revenue
- PLUR $678,000.00
- PASG N/A
- Revenue This Year
- PLUR $472.39
- PASG N/A
- Revenue Next Year
- PLUR $254.29
- PASG N/A
- P/E Ratio
- PLUR N/A
- PASG N/A
- Revenue Growth
- PLUR 89.92
- PASG N/A
- 52 Week Low
- PLUR $3.33
- PASG $0.30
- 52 Week High
- PLUR $6.60
- PASG $1.64
- Technical
- Relative Strength Index (RSI)
- PLUR 80.65
- PASG 41.07
- Support Level
- PLUR $3.36
- PASG $0.31
- Resistance Level
- PLUR $3.92
- PASG $0.40
- Average True Range (ATR)
- PLUR 0.48
- PASG 0.05
- MACD
- PLUR 0.24
- PASG 0.00
- Stochastic Oscillator
- PLUR 90.00
- PASG 30.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.